CoChat

Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers

Open access

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Objective: Although SLE disproportionately affects minority racial groups, they are significantly under-represented in clinical trials in the USA. This may lead to misleading conclusions in race-based subgroup analyses. We conducted focus groups to evaluate the perceptions of diverse patients with lupus about clinical trial participation. Methods: A qualitative research design employed three 90 min focus groups led by a trained moderator and guided by the Theory of Planned Behaviour. Open-ended questions about trial participation included advantages and disadvantages (behavioural beliefs), approving and disapproving significant others (normative beliefs), and participation enhancers and barriers (control beliefs). Discussions were recorded, transcribed and analysed to identify emerging themes. Results: Patients with SLE (n=23) aged 21–72, with increased proportion of minority groups (65%), participated. Reported advantages of trial participation included altruism and personal benefit. Disadvantages included uncertainties, disappointment, information burden, and life–health balance. Although some patients had discussed research participation with approving or disapproving family or friends, self-approval superseded external approval. Barriers included logistics and time, and facilitators included flexibility in scheduling, advance notice of studies, streamlined forms, and hope for SLE improvement. Conclusions: Knowledge about potential benefits of clinical trial participation was high. Minority patients demonstrated confidence in making their own informed decisions, but major barriers for all participants included burdensome forms, travel, childcare, and work. These suggest a major impact on minority and all recruitment from behavioural and control aspects, which should be considered in the logistics of trial design. This does not minimise the potential importance of improved access and education about clinical research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/lupus-2019-000360

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Patient recruitment flow chart. Patients were contacted to determine their interest in participation in the focus groups. A message was left for those who did not answer the phone; however, 15 did not return the calls. Others were unable to participate and gave various reasons, including 11 who had other plans on the dates chosen for the focus groups.
Figure 1 Patient recruitment flow chart. Patients were contacted to determine their interest in participation in the focus groups. A message was left for those who did not answer the phone; however, 15 did not return the calls. Others were unable to participate and gave various reasons, including 11 who had other plans on the dates chosen for the focus groups.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

See all 23

Metadata

Authors
Arriens, C., Aberle, T., Carthen, F., Kamp, S., Thanou, A., Chakravarty, E., James, J. A., Merrill, J. T., & Ogunsanya, M. E.
Affiliations
  • Oklahoma Medical Research Foundation (US)
  • University of Oklahoma Health Sciences Center (US)
Corresponding author
Arriens, Cristina
Venue
Lupus Science & Medicine
Publisher
BMJ
Published
2020-03
Volume
7
Issue
1
Pages
e000360
ISSN
2053-8790 (ISSN-L)
OpenAlex
W3011719344
Cited by
19
References
37
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2023: 7 · 2022: 4 · 2021: 2
FWCI
2.43
Type
journal article
Language
en
Open access
Locations
  • Lupus Science & Medicine (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
U.S. Department of Health and Human Services: Office of Minority Health (CPI-MP-17-002-1 2017 National Lupus Outreach)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Keywords
systemic lupus erythematosus, clinical trial participation, patient decision-making, minority patients, underrepresentation in clinical trials, theory of planned behavior, barriers to clinical trial participation, informed consent, patient recruitment, altruism, family and friend influence
MeSH terms
Adult, Aged, Altruism, Clinical Trials as Topic, Culture, Decision Making, Female, Humans, Health Knowledge, Attitudes, Practice, Lupus Erythematosus, Systemic, Male, Middle Aged, Minority Groups, Oklahoma, Patient Participation, Perception, Focus Groups, Qualitative Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers. https://app.cochat.ai/papers/10.1136/lupus-2019-000360
The paper
Arriens, C., Aberle, T., Carthen, F., Kamp, S., Thanou, A., Chakravarty, E., James, J. A., Merrill, J. T., & Ogunsanya, M. E. (2020). Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers. Lupus Science & Medicine. https://doi.org/10.1136/lupus-2019-000360

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.